About the Laboratory
The Structural Genomics Laboratory (GenEstrut) at the Federal University of Pelotas is dedicated to advancing genomic science while translating discoveries into solutions for health, biotechnology and society.
The Structural Genomics Laboratory was founded and is coordinated by Prof. Vinicius Farias Campos, whose leadership has shaped GenEstrut’s identity: frontier science guided by real-world challenges and committed to transforming knowledge into societal impact. The group also counts on the collaboration of Profa. Mariana Härter Remião, who serves as Deputy Head of the laboratory, and Prof. Tony Leandro Rezende da Silveira, coordinator of the Biomodels Facility.
Established in may of 2015 at the Center for Technological Development (CDTec), the laboratory has grown into one of Brazil’s leading academic groups working at the interface of molecular biology, bioinformatics, experimental models and applied biotechnology.
GenEstrut brings together researchers, students and collaborators working across multiple areas of genomic science, including structural and functional genomics, epigenetics, microRNA biology, molecular diagnostics, precision medicine, environmental genomics and animal biotechnology. By integrating experimental biology, bioinformatics, artificial intelligence and translational research, the laboratory develops scientific and technological solutions with applications in human health, animal production, aquaculture, environmental monitoring and public health.
Since its creation, the laboratory has maintained a consistent and internationally connected research program. Between 2015 and 2025, GenEstrut researchers have published more than one hundred peer-reviewed scientific articles and contributed to books and book chapters, reflecting the group’s active participation in global scientific networks and collaborations across Latin America, Europe and the United States.
Beyond scientific production, the laboratory places strong emphasis on training the next generation of scientists and innovators. GenEstrut operates as a research and training hub for undergraduate, master’s, doctoral and postdoctoral researchers linked to graduate programs in biotechnology, biochemistry, bioprospecting and veterinary sciences at UFPel. Over the past decade, the laboratory has trained dozens of researchers who now work in academia, technology companies, startups, healthcare institutions and public agencies, demonstrating the applied and interdisciplinary nature of the group’s training model.
Innovation and technology transfer are central components of the laboratory’s mission. GenEstrut has contributed to the development of multiple technologies in genomics and biotechnology, resulting in dozens of patent filings, granted patents and the creation of science-based startups. Among these achievements, the laboratory has already licensed patented technologies involving microRNA-based molecular applications, reinforcing its role in translating genomic discoveries into real-world solutions.
The work conducted at GenEstrut has also been recognized through several national scientific awards and distinctions, reflecting the impact of its research, innovation activities and contributions to scientific training and technological development.
The laboratory has also demonstrated its capacity to respond to societal challenges. During the COVID-19 pandemic, GenEstrut played a key role in implementing the Molecular Diagnostic Unit at the UFPel Teaching Hospital, contributing to the processing of more than 10,000 molecular tests for SARS-CoV-2 and supporting the regional public health response.
Today, GenEstrut represents more than a research laboratory. It functions as a dynamic platform connecting science, technology, training and innovation, working collaboratively with universities, companies, hospitals and public institutions. Through this integrated approach, the laboratory seeks to expand access to genomic technologies, strengthen public health systems and contribute to sustainable scientific and technological development.